本頁面由Tiger Trade Technology Pte. Ltd.提供服務

諾和諾德

43.07
-0.9400-2.14%
盤後43.110.0400+0.09%19:59 EDT
成交量:1,102.91萬
成交額:4.74億
市值:1,923.08億
市盈率:10.76
高:43.50
開:43.20
低:42.72
收:44.01
52周最高:64.16
52周最低:35.12
股本:44.65億
流通股本:31.88億
量比:1.35
換手率:0.35%
股息:1.72
股息率:4.00%
每股收益(TTM):4.00
每股收益(LYR):3.62
淨資產收益率:59.82%
總資產收益率:18.73%
市淨率:5.91
市盈率(LYR):11.90

資料載入中...

2026/06/22

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2026/06/22

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2026/06/22

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/02/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/06/27

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/06/27

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/05/30

關聯方擬減持公告

Form 144 | Innate Pharma SA 10% 股東 Novo Nordisk A/S 擬減持921897股,總價約197萬美元
2025/02/05

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/21

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/21

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/01/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/11/24

SEC問詢函

Form CORRESP - Correspondence
2023/11/09

SEC問詢函

Form CORRESP - Correspondence
2023/10/20

SEC問詢函

Form CORRESP - Correspondence
2023/09/29

SEC問詢函

Form CORRESP - Correspondence
2023/09/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/28

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/06/28

員工持股計劃

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/02/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]